Filing Details
- Accession Number:
- 0001415889-22-012359
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-09 21:05:19
- Reporting Period:
- 2022-12-07
- Accepted Time:
- 2022-12-09 21:05:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1711968 | Leonard Steven Chapman | C/O Natera, Inc. 13011 Mccallen Pass Building A Suite 100 Austin TX 78753 | Ceo And President | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-07 | 9,158 | $9.29 | 82,484 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2022-12-07 | 1,146 | $13.01 | 83,630 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-12-07 | 2,645 | $38.31 | 80,985 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2022-12-07 | 9,158 | $0.00 | 9,158 | $9.29 |
Common Stock | Stock Option (right to buy) | Disposition | 2022-12-07 | 1,146 | $0.00 | 1,146 | $13.01 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2028-03-08 | No | 4 | M | Direct | |
23,949 | 2029-01-10 | No | 4 | M | Direct |
Footnotes
- The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter.
- The option shares vest over four years. 25% of the option shares vested and became exercisable on January 2, 2020 and the remaining shares vest in 36 equal monthly installments thereafter.